DXB 1.08% 47.0¢ dimerix limited

Ann: Quarterly Appendix 4C and Activities Report, page-31

  1. 155 Posts.
    lightbulb Created with Sketch. 38
    Maybe some investors are cautious following previous results, but that was years ago and the company have learned and adapted accordingly. Risk vs reward here is ridiculous as those prices haven't factored in clinically significant data, only assessed based on phase 3 trials. If the results are clinically significant, hold on to your hats

    dyor and gltah
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
47.0¢
Change
0.005(1.08%)
Mkt cap ! $266.8M
Open High Low Value Volume
47.0¢ 49.0¢ 46.5¢ $1.088M 2.282M

Buyers (Bids)

No. Vol. Price($)
8 255084 46.5¢
 

Sellers (Offers)

Price($) Vol. No.
47.0¢ 58764 4
View Market Depth
Last trade - 13.11pm 29/07/2024 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.